Krishnan Krish S: insider trades.
Krishnan Krish S reported 13 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($9.0M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 13
- Companies
- 1
- Name as filed
- Krishnan Krish S
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Director, Officer, TenPercentOwner · President and CEO | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Krystal Biotech, Inc. | S | 1,358 | $364.48 | 1,348,795 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 847 | $365.42 | 1,347,948 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 405 | $366.56 | 1,347,543 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 520 | $354.54 | 1,372,023 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 2,029 | $355.57 | 1,369,994 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 3,297 | $356.37 | 1,366,697 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 3,981 | $357.57 | 1,362,716 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 3,143 | $358.42 | 1,359,573 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 3,357 | $359.39 | 1,356,216 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 2,266 | $360.46 | 1,353,950 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 1,214 | $361.61 | 1,352,736 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 2,010 | $362.65 | 1,350,726 | Form 4 |
| 2026-09-04 | Krystal Biotech, Inc. | S | 573 | $363.34 | 1,350,153 | Form 4 |
Questions
What stock did Krishnan Krish S buy or sell?
Krishnan Krish S reported 13 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($9.0M), across 1 company.
Is Krishnan Krish S the same person as other filers with this name?
This page covers SEC CIK 1298709 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/krishnan-krish-s-1298709.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.